跳至主要内容
临床试验/NL-OMON44019
NL-OMON44019已完成不适用

A Multicenter Clinical Evaluation Study to Determine the External Site Accuracy of Total Immunoglobulin E Measurement using a Novel Point-of-Care Test Device Compared to a Reference Method in Atopic Subjects - DIGE0012201

ovartis0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
ovartis
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion criteria for patients:
  • 1. Male or female subjects who are aged *18 years.
  • 2. Subjects who are diagnosed with atopic asthma or other atopic condition for a minimum of 6 months prior to study entry. There should be documented evidence of sensitization to one or more specific allergens.;Inclusion criteria for healthy volunteers: N/A for the Netherlands. Besides, adults only (minimum age of 18) will be included in the Netherlands.

排除标准

  • Exclusion criteria for patients:
  • 1. Subjects who have received treatment with omalizumab or other anti-IgE antibody treatment in the past 6 months.
  • 2. Subjects who have elevated serum IgE levels for reasons other than allergic conditions (e.g., parasite infections, hyperimmunoglobulin E syndrome, Wiskott-Aldrich syndrome, or bronchopulmonary aspergillosis).;Exclusion criteria for healthy volunteers: N/A for the Netherlands.

研究者

发起方
ovartis

相似试验

A Multicenter Clinical Evaluation Study to Determine... | 临床试验